Reduction in transforming growth factor-β type II receptor in mouse lung carcinogenesis

Molecular Carcinogenesis

Volumn 22, Issue 1, 1998, Pages 46-56

  Jakowlew, Sonia B ^a   Moody, Terry W ^a   You, Liang ^a   Mariano, Jennifer M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

A J mouse; Chemical carcinogenesis; Gene expression; Tumor progression

Indexed keywords

PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; URETHAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLE; CELL GROWTH; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GROWTH INHIBITION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG ADENOMA; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROBE; TUMOR GROWTH;

EID: 0031804982     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199805)22:1<46::AID-MC6>3.0.CO;2-J     Document Type: Article

References (43)

1. Cancer Facts and Figures. 1996. American Cancer Society, Inc., Atlanta, GA, 1996.
2. Ginsberg RJ. Multimodality therapy for stage IIIA (N2) lung cancer. An overview. Chest 103:356s-359s, 1993.
3. Malkinson AM. Primary lung tumors in mice: An experimentally manipulate model of human adenocarcinoma. Cancer Res (Suppl) 52:2670s-2676s, 1992.
4. You M, Candrian U, Maronpot RR, Stoner GD, Anderson MW. Activation of the K-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc Natl Acad Sci USA 86:3070-3074, 1989.
5. Roberts AB, Sporn MB. The transforming growth factor-βs. In: Sporn MB, Roberts AB (eds), Handbook of Experimental Pharmacology. Springer-Verlag, Berlin, pp 419-472, 1990.
6. Roberts AB, Heine UI, Flanders KC, Sporn MB. Transforming growth factor-β: Major role in regulation of extracellular matrix. Ann NY Acad Sci 580:225-232, 1990.
7. Massague' J, Cheifetz S, Laiho M, Ralph DA. Transforming growth factor-beta. Cancer Surv 12:81-103, 1992.
8. Chiefetz S, Weatherbee JA, Tsang ML-S, et al. The transforming growth factor-beta system, a complex pattern of cross reactive ligands and receptors. Cell 48:409-415, 1987.
9. Massague' J, Attisano L, Wranna J. The TGF-β family and its composite receptors. Trends Cell Biol 4:172-178, 1994.
10. Manning A, Williams A, Game S, Paraskeva C. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGF β): Conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-β. Oncogene 6:1471-1476, 1991.
11. Markowitz S, Wang J, Myerhoff L, et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338, 1995.
12. Myerhoff LL, Parsons R, Kim S-J, et al. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55:5545-5547, 1995.
13. Parsons R, Myerhoff LL, Liu B, et al. Microsatellite instability and mutations of the TGF-β type II receptor gene in colorectal cancer. Cancer Res 55:5548-5550, 1995.
14. Garrigue-Antar L, Munoz-Antonia T, Antonia S, Gesmonde J, Vellucci V, Reiss M. Missense mutations of the transforming growth factor β type II receptor in head and neck squamous carcinoma cells. Cancer Res 55:3982-3987, 1995.
15. Wang J, Sun LZ, Myerhoff L, et al. Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 270:22044-22049, 1995.
16. Munoz-Antonia T, Li X, Reiss M, Jackson R, Antonia S. A mutation in the transforming growth factor β type II receptor gene promoter associated with loss of gene expression. Cancer Res 56:4831-4835, 1996.
17. Baldwin RL, Friess H, Yokoyama M, et al. Attenuated ALK5 receptor expression in human pancreatic cancer: Correlation with resistance to growth inhibition. Int J Cancer 67:283-288, 1996.
18. DeCoteau JF, Knaus PI, Yankelev H, et al. Loss of functional cell surface transforming growth factor β (TGF-β) type I receptor correlates with insensitivity to TGF-β in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 94:5877-5881, 1997.
19. Jakowlew SB, Mathias A, Chung P, Moody TW. Expression of transforming growth factor β ligand and receptor messenger RNAs in lung cancer cell lines. Cell Growth Differ 6:465-476, 1995.
20. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299, 1979.
21. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 80:1991-1995, 1984.
22. Qian SW, Kondaiah P, Roberts AB, Sporn MB. cDNA cloning by PCR of rat transforming growth factor-β1. Nucleic Acids Res 8:3059, 1990.
23. Miller DA, Lee A, Pelton RW, Chen EY, Moses HL, Derynck R. Murine transforming growth factor-β2 cDNA sequence and expression in adult tissues and embryos. Mol Endocrinol 3:1108-1114, 1989.
24. Denhez F, Lafyatis R, Kondaiah P, Roberts AB, Sporn MB. Cloning by polymerase chain reaction of a new mouse TGF-β, TGF-β3. Growth Factors 3:1325-1345, 1990.
25. Franzen P, ten Dijke P, Ichijo H, et al. Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 75:681-692, 1993.
26. Lin HY, Wang X-F, Ng-Eaton E, Weinberg RA, Lodish HF. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785, 1992.
27. Wang X-F, Lin HY, Ng-Eaton E, Downward J, Lodish HF, Weinberg RA. Expression cloning and characterization of the TGF-β type III receptor. Cell 67:797-805, 1991.
28. Mahmoud S, Staley J, Taylor J, et al. (Psi 13, 14) bombesin analogues inhibit the growth of small cell lung cancer in vitro and in vivo. Cancer Res 51:1798-1802, 1991.
29. Jakowlew SB, Kondaiah PK, Flanders KC, et al. Increased coordinate expression of growth factor mRNAs accompanies viral transformation of rodent cells. Oncogene Res 2:135-148, 1988.
30. Jakowlew SB, Moody TW, Mariano JM. Transforming growth factor-beta receptors in human cancer cell lines: Analysis of transcript, protein and proliferation. Anticancer Res 17:1849-1860, 1997.
31. Allen JW, Stoner GD, Pereira MA, Backler LC. Tumorigenesis and genotoxicity of ethyl carbamate and vinyl carbamate in rodent cells. Cancer Res 46:4911-4915, 1986.
32. Chen B, Johanson L, Wiest JS, Anderson MW, You M. The second intron of K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility. Proc Natl Acad Sci USA 91:1589-1593, 1994.
33. Massey TE, Devereaux TR, Maronpot RR. High frequency of K-ras mutations in spontaneous and vinyl carbamate-induced lung tumors of relatively resistant B6CF1 (C57B1/6JxBALB/cJ) mice. Carcinogenesis 16:1065-1069, 1995.
34. Damstrup L, Rygaard K, Spang-Thomsen M, Poulson HS. Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2, TGF-beta 3 in human small cell lung cancer cell lines. Br J Cancer 68:1015-1021, 1993.
35. Norgaard P, Damstrup L, Rygaard K, Spang-Thomsen M, Skovgaard HP. Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor. Br J Cancer 69:802-808, 1994.
36. Jasani B, Wylie FS, Wright PA, Lemoine NR, Williams ED, Wynford-Thomas D. Immunohistochemically detectable TGF-β is associated with malignancy in thyroid epithelial neoplasia. Growth Factors 2:149-155, 1990.
37. Hirayama D, Fujimomi K, Satonaka K. Immunohistochemical study of epidermal growth factor and transforming growth factor-β in the penetrating type of early gastric cancer. Human Pathol 23:681-685, 1992.
38. Johnson MD, Federspiel CF, Gold LI, Moses HL. Transforming growth factor-β and transforming growth factor β receptor expression in human meningioma cells. Amer J Pathol 141:633-642, 1992.
39. Gorsh SM, Memoli VA, Stukel TA, Gold LI, Arrick BA. Immunohistochemical staining for transforming growth factor-β1 associates with disease progression in human breast cancer. Cancer Res 52:6949-6952, 1992.
40. Steiner MS, Barrack ER. Transforming growth factor-β1 overproduction in prostate cancer: Effects on growth in vivo and in vitro. Mol Endocrinol 6:15-25, 1992.
41. Friess H, Yamahaka Y, Buchler M. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105:1846-1856, 1993.
42. Shirai Y, Kawata S, Tamura S. Plasma transforming growth factor-β1 in patients with hepatocellular carcinoma. Cancer 73:2275-2279, 1994.
43. Anzano MA, Roberts AB, DeLarco JE, et al. Increased secretion of type beta transforming growth factor accompanies viral transformation. Mol Cell Biol 5:242-247, 1985.